EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, CNTA: Centessa Pharmaceuticals Plc ADR

11 Dec 25 11:32
LAST:

27.96

CHANGE:
 1.61		OPEN:
29.69		HIGH:
29.79		ASK:
0.00		VOLUME:
1.91M
CHG(%):
5.44		PREV:
29.57		LOW:
26.50		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
11 Dec 2529.6929.7926.5027.961.91M
10 Dec 2529.1130.0228.7229.57972.5K
09 Dec 2529.3029.7428.4328.60955.2K
08 Dec 2529.8630.5829.4229.50828.5K
05 Dec 2529.3130.0028.9529.91887.8K
04 Dec 2529.0029.7428.5229.56666.1K
03 Dec 2528.3529.5228.3529.072.02M
02 Dec 2528.4229.1428.1928.511.27M
01 Dec 2529.6329.7728.1928.471.68M
28 Nov 2529.1729.5228.9629.031.22M

PROFILE

Name:Centessa Pharmaceuticals Plc ADR
About:Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines. Its lead clinical-stage program includes ORX750, an orally administered OX2R agonist in a Phase 2a study for the treatment of idiopathic hypersomnia and narcolepsy type 1 and 2. The company also develops ORX142 for the treatment of neurological and neurodegenerative disorders, as well as other potential symptoms, including excessive daytime sleepiness, impaired attention, cognitive deficits, and fatigue; and ORX489 for the treatment of neuropsychiatric disorders. In addition, it offers LockBody, which is designed to selectively drive potent effector function activity, such as CD3, into the tumor microenvironment. Centessa Pharmaceuticals plc was incorporated in 2020 and is headquartered in Altrincham, the United Kingdom.
Sector:Healthcare
Industry:Biotechnology
Address:1 Ashley Road, Altrincham, United Kingdom, WA14 2DT
Website:https://centessa.com
CUSIP:152309100
CIK:0001847903
ISIN:US1523091007
FIGI:BBG01081FC59

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-11.62 
Forward P/E:-14.03 
PEG Ratio:2.32 
Price to Sales:214.43 
Price to Book:9.31 
Operating Margin:-13.76 
Return on Assets:-0.29 
Return on Equity:-0.73 
EPS Ratio:-1.85 
Revenue:15.0M 
Shares:134.07M 
Market Cap:3.749B 

TECHNICAL INDICATORS

MA5:29.114.1%
MA10:29.023.8%
MA20:28.512.0%
MA50:25.4010.1%
MA100:22.0926.6%
MA200:17.8956.3%
RSI14:52.56
WPR14:-100.00 
MTM14:-0.02
ROC14:0.00 
ATR:1.37 
Week High:30.589.4%
Week Low:26.505.5%
Month High:30.589.4%
Month Low:21.9756.3%
Year High:30.589.4%
Year Low:9.60191.3%
Volatility:71.10